Inogen Inc (INGN) Live Share Price, Invest From India

Inogen Inc Stock Performance

as on March 13, 2026 at 6:59 am IST

Day's Low
Day's High
$6.07
Day's Price Range
$6.23
$6.11
0.65%
Downside
1.96%
Upside
52 Week's Low
52 Week's High
$5.34
52-Week Price Range
$9.13
$6.11
12.60%
Downside
49.43%
Upside

Inogen Inc share price movements today

Previous Close: $6.23
Open: $6.14
Volume: 326.3K
Day's Low - High: $6.07 - $6.23
52 Week Low - High: $5.34 - $9.13

Inogen Inc Historical Returns

1 Month Return: + 7.6 %
3 Month Return: -11.76 %
1 Year Return: -20.94 %
3 Year Return: -53.75 %
5 Year Return: -87.93 %

Inogen Inc Stock Fundamentals & Key Indicators

Check Inogen Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$169.4M

EPS (TTM)

-0.52

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.87%

PE Ratio (TTM)

-3.27

Industry PE ratio

-3.2145878136200716

PEG Ratio

3.48

EBITDA

-9.5M

Revenue (TTM)

348.7M

Profit Margin

-6.52%

Return On Equity TTM

-12.43%

Inogen Inc Stock Valuation

Track how Inogen Inc P/E has moved over time to understand its valuation trends.

Inogen Inc in the last 5 years

Overview
Trends

Lowest (-125.28x)

December 31, 2021

Today (-3.27x)

March 12, 2026

Industry (-3.21x)

March 12, 2026

Highest (125.47x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -3.27x

Inogen Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Inogen Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Inogen Inc	SELL	$169.4M	-87.93%	-3.27	-6.52%
Boston Scientific Corp.	BUY	$103.8B	79.23%	36.06	14.44%
Stryker Corporation	BUY	$137.3B	43.62%	42.75	12.92%
Medtronic Plc	BUY	$115.4B	-25.12%	25.11	13.00%
Edwards Lifesciences Corp.	BUY	$49.4B	3.68%	47.27	17.69%

See all

Stock Returns calculator for Inogen Inc Stock including INR - Dollar returns

The Inogen Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inogen Inc investment value today

Current value as on today

₹83,327

Returns

₹16,673

(-16.67%)

Returns from Inogen Inc Stock

₹22,462 (-22.46%)

Dollar Returns*

₹5,789 (+5.79%)

Analyst Recommendation on Inogen Inc Stock

Based on 9 analysts

SELL

11.11%

Buy

44.44%

Hold

44.44%

Sell

Based on 9 analysts, 44.44% of analysts recommend a 'SELL' rating for Inogen Inc. Average target price of $13

Inogen Inc Share Price Target

Get share price movements and forecasts by analysts on Inogen Inc.

What analysts predicted

53%UPSIDE

Target Price

$13

Current Price

$6.11

Analyzed by

9 Analysts

Target

$13.00

Inogen Inc target price $13, a slight upside of 53% compared to current price of $6.11. According to 9 analysts rating.

Inogen Inc Stock’s Investor Sentiment and Interest

Search interest for Inogen Inc Stock has increased by 403% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 11, 2026 to March 13, 2026

Change:403% versus previous 30 day period

Inogen Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	83	75	78	88	88	80	82	92	92	81
Gross Profit	33	28	34	42	41	36	36	41	46	41
Operating Income	-46	-28	-16	-7	-7	-11	-7	-6	-7	-9
EBITDA	-9	-23	-11	-1	-2	-6	-2	0	0	-2
Interest Expense	-	1	-	-	-	-	-	-	-	-
Depreciation	4	5	5	5	5	5	5	5	5	5
Income Before Tax	-45	-27	-14	-5	-6	-10	-6	-4	-5	-7
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-45	-26	-14	-5	-5	-9	-6	-4	-5	-7
Net Profit Margin	-54.45%	-34.99%	-18.68%	-6.30%	-6.71%	-12.18%	-7.50%	-4.50%	-5.73%	-8.72%

Inogen Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	202	249	358	361	308	358	377	315	335	348
Gross Profit	97	121	178	171	138	176	153	126	154	165
Operating Income	22	27	37	19	-12	9	-85	-109	-42	-30
EBITDA	36	39	49	33	6	30	-9	-58	-21	-2
Interest Expense	0	-	-	18	25	21	2	-	-	-
Depreciation	-	12	11	13	18	21	23	18	21	20
Income Before Tax	22	29	40	24	-5	8	-83	-102	-36	-23
Income Tax Expense	2	8	-11	3	0	14	0	0	0	0
Net Income	20	21	51	20	-5	-6	-83	-102	-35	-22
Net Profit Margin	10.12%	8.42%	14.48%	5.79%	-1.89%	-1.77%	-22.21%	-32.46%	-10.69%	-6.52%

Inogen Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-26	-14	-5	-5	-9	-6	-4	-5	-7
Operating Cash Flow	-3	-4	6	6	-3	-16	4	2	0
Investing Cash Flow	4	-13	-12	0	11	-2	-22	0	-1
Financing Cash Flow	0	0	0	0	0	23	-	0	0
Change in Cash	0	-49	-5	7	8	5	-17	2	-2

Inogen Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	21	51	20	-5	-6	-83	-102	-35	-22
Operating Cash Flow	60	59	40	37	23	-37	-3	5	-11
Investing Cash Flow	-24	-24	-44	-25	-14	-10	-59	-13	-26
Financing Cash Flow	14	18	4	2	15	0	0	0	24
Change in Cash	50	53	1	13	23	-48	-61	-8	-12

Global Institutional Holdings in Inogen Inc

Funds	Holdings
Camber Capital Management LLC	3.61%
Dafna Capital Management LLC	3.04%
Nuveen, LLC	1.61%
Morgan Stanley - Brokerage Accounts	2.22%
Federated Hermes Inc	1.57%

See all

Insights on Inogen Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 11.1% return, outperforming this stock by 64.2%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 25.2% return, outperforming this stock by 41.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -4.15M → -7.12M (in $), with an average decrease of 31.1% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, INGN stock has moved down by -3.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 92.39M → 81.72M (in $), with an average decrease of 11.6% per quarter

About Inogen Inc

inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take

Organisation	Inogen Inc
Headquarters	500 Cummings Center, Beverly, MA, United States, 01915
Industry	Health Technology
CEO	Mr. Kevin R. M. Smith
E-voting on shares	Click here to vote

Key Management of Inogen Inc

Name	Title
Mr. Grgoire Ramade	Executive VP & Chief Commercial Officer
Mr. Philip Corrin	Senior Vice President of Operations & Supply Chain
Ms. Mary Wright	VP & Chief Accounting Officer
Ms. Jennifer Yi Boyer	Executive VP of Enterprise Enablement & Chief Human Resources Officer
Dr. Krishna Jhaveri	Chief Medical Officer
Mr. Kevin P. Smith	General Counsel, Secretary & Executive VP of Business Development
Mr. Naga Rameswamy	Chief Technology Officer
Ms. Lorna Williams	Senior Vice President of Investor Relations
Mr. Paul Andreassi	Executive VP and Chief Quality & Regulatory Affairs Officer
Mr. Kevin R. M. Smith	President, CEO & Director

FAQs

What is Inogen Inc share price today?

Inogen Inc share price today is $6.11 as on March 13, 2026 at 1:29 am IST at the close of the market. Inogen Inc share today touched a day high of $6.23 and a low of $6.07.

What is the 52 week high and 52 week low for Inogen Inc share?

Inogen Inc share touched a 52 week high of $9.13 on October 22, 2025 and a 52 week low of $5.34 on February 25, 2026. Inogen Inc stock price today i.e. March 13, 2026 at 1:29 am IST is closed at $6.11,which is 33.08% down from its 52 week high and 14.42% up from its 52 week low.

What is Inogen Inc's market capitalisation today?

Inogen Inc market capitalisation is $0.00T as on March 13, 2026 at 1:29 am IST.

How to invest in Inogen Inc Stock (INGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inogen Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inogen Inc Shares that will get you 0.2455 shares as per Inogen Inc share price of $6.11 per share as on March 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Inogen Inc Stock (INGN) from India?

Indian investors can start investing in Inogen Inc (INGN) shares with as little as ₹92.206 or $1 (as of March 13, 2026 at 7:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹922.06 in Inogen Inc stock (as per the Rupee-Dollar exchange rate as on March 13, 2026 at 7:38 am IST). Based on Inogen Inc share’s latest price of $6.11 as on March 13, 2026 at 1:29 am IST, you will get 1.6367 shares of Inogen Inc. Learn more about fractional shares .

What are the returns that Inogen Inc has given to Indian investors in the last 5 years?

Inogen Inc stock has given -87.93% share price returns and 26.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?